Loading
Latest filing published 16 Jul 2026 for Monte Rosa Therapeutics, Inc., €192k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 16 July 2026, Markus Warmuth disclosed a transaction of €192k in Monte Rosa Therapeutics, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration